Literature DB >> 2569031

Genetic factors in sleep disorders.

J D Parkes1, C B Lock.   

Abstract

Several sleep disorders have a genetic basis. These conditions include the narcoleptic syndrome, sleep walking, periodic movements in sleep, circadian delay syndromes and familial insomnia. These disorders illustrate different control mechanisms involved in sleep and wakefulness, including those determining the prevalence and timing of NREM and REM activity, somatomotor inhibition and excitation, autonomic discharge, and the circadian framework of sleep. The genetic defect in narcolepsy has been localised to the short arm of chromosome 6, but the chromosomal localisations of the genetic basis for the other disorders are not known. Also, with the possible exception of acetylcholine, no definite neurotransmitter involved in any aspect of sleep regulation has been positively identified and the biochemical defect in narcolepsy is not known.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569031      PMCID: PMC1033314          DOI: 10.1136/jnnp.52.suppl.101

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  47 in total

1.  Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis.

Authors:  A Marcadet; C Massart; G Semana; R Fauchet; O Sabouraud; M Merienne; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  HLA-DR2 and narcolepsy: not all narcoleptic-cataplectic patients are DR2.

Authors:  C Guilleminault; C Grumet
Journal:  Hum Immunol       Date:  1986-09       Impact factor: 2.850

3.  Possible male segregation distortion of DR2 haplotypes in narcolepsy patients.

Authors:  G Mueller-Eckhardt; P Strohmaier; D J Schendel; K Meier-Ewert; C Mueller-Eckhardt
Journal:  Hum Immunol       Date:  1987-11       Impact factor: 2.850

4.  Muscarinic cholinergic receptors and the canine model of narcolepsy.

Authors:  T S Kilduff; S S Bowersox; K I Kaitin; T L Baker; R D Ciaranello; W C Dement
Journal:  Sleep       Date:  1986       Impact factor: 5.849

5.  DR2-negative narcolepsy.

Authors:  A Andreas-Zietz; E Keller; S Scholz; E D Albert; B Roth; S Nevsimalova; K Sonka; P Docekal; E Ivaskova; H Schulz
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

6.  Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat.

Authors:  I Tobler; A A Borbély; M Schwyzer; A Fontana
Journal:  Eur J Pharmacol       Date:  1984-09-03       Impact factor: 4.432

7.  Class II genes of the human major histocompatibility complex. Organization and evolutionary relationship of the DR beta genes.

Authors:  G Andersson; D Larhammar; E Widmark; B Servenius; P A Peterson; L Rask
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

8.  Narcolepsy following cerebral hypoxic ischemia.

Authors:  V M Rivera; J S Meyer; T Hata; Y Ishikawa; A Imai
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

9.  Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin.

Authors:  H Schrader; O B Gotlibsen; G N Skomedal
Journal:  Neurology       Date:  1980-01       Impact factor: 9.910

10.  HLA and narcolepsy in a German population.

Authors:  G Mueller-Eckhardt; K Meier-Ewert; D J Schendel; F B Reinecker; G Multhoff; C Mueller-Eckhardt
Journal:  Tissue Antigens       Date:  1986-09
View more
  1 in total

1.  Autonomic function in narcolepsy: power spectrum analysis of heart rate variability.

Authors:  L Ferini-Strambi; A Spera; A Oldani; M Zucconi; A Bianchi; S Cerutti; S Smirne
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.